What are the potential consequences of restricting access to puberty blockers and hormone replacement therapy for trans youth?
Last June, the UK's National Health System (NHS) decided to suspend the provision of puberty blockers to transgender youth in gender identity clinics. This decision moves in the opposite direction of US policies in blue states, where trans individuals are gaining more rights and access to healthcare.
In today's episode, we discuss the implications of the UK's NHS healthcare policies for transgender youth and compare them with the more progressive approaches adopted in many states in the US. We explore the role of medical professionals in shaping these policies and the challenges trans youth face in accessing essential healthcare services.
Additionally, we delve into the statements made by the Vatican condemning gender fluidity as we shed light on the intersection of religious beliefs and LGBTQ+ rights.
In This Episode, You Will Learn:
Resources Mentioned:
Connect with Jackie and Bridget:
","author_name":"Bridget Sampson"}